Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show
Spring on the Road
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Scinai Immunotherapeutics Ltd. - American Depositary Shares
(NQ:
SCNI
)
3.340
+0.100 (+3.09%)
Streaming Delayed Price
Updated: 3:48 PM EST, Feb 14, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Scinai Immunotherapeutics Ltd. - American Depositary Shares
< Previous
1
2
3
4
5
Next >
BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) CEO Releases Shareholder Letter
January 04, 2024
Via
Investor Brand Network
Shining Spotlight on How Vitiligo Could Be Connected to Other Autoimmune Disorders
January 03, 2024
Via
Investor Brand Network
12 Health Care Stocks Moving In Monday's Pre-Market Session
January 01, 2024
Via
Benzinga
BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Enters Agreement for Million-Dollar Exercise of Outstanding Warrants
December 29, 2023
Via
Investor Brand Network
Potential Complications of Untreated Psoriasis
November 02, 2023
Via
Investor Brand Network
BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Announces January Analyst, Investor Webinar
December 27, 2023
Via
Investor Brand Network
New Research Redefines Pathophysiology of Rheumatoid Arthritis, Paves Way for Precision Treatments
December 20, 2023
Via
Investor Brand Network
BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Reports on Preclinical Results from Psoriatic Human Skin Trial
December 12, 2023
Via
Investor Brand Network
BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Announced Peer-Reviewed Journal Publishes Data Supporting NanoAbs
December 11, 2023
Via
Investor Brand Network
Exposures
COVID-19
Many Fellowship Programs for Infectious Disease Specialists Remain Unfilled in US
December 08, 2023
Via
Investor Brand Network
BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Announces Maturity Extension of EIB Finance Facility
November 29, 2023
Via
Investor Brand Network
Autoimmunity Patients Face Cost, Diagnosis, Care Challenges
November 28, 2023
Via
Investor Brand Network
New, Deadly Infectious Diseases Could Emerge as Climate Change Worsens
November 14, 2023
Via
Investor Brand Network
Topics
Climate Change
Exposures
Climate
BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Receive $900K IIA Grant for New CDMO Business Unit
November 07, 2023
Via
Investor Brand Network
Topics
Economy
Exposures
Economy
BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Releases Status Report on NASDAQ Compliance
November 06, 2023
Via
Investor Brand Network
Scinai Immunotherapeutics Announces Award of Non-Dilutive Grant from Israel Innovation Authority Supporting its New CDMO Business Unit
November 06, 2023
From
Scinai Immunotherapeutics Ltd.
Via
GlobeNewswire
Scinai Immunotherapeutics Provides Update Regarding Nasdaq Compliance
November 03, 2023
From
Scinai Immunotherapeutics Ltd.
Via
GlobeNewswire
BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Releases Q3 2023 Financial Report, Reports Possible Adjustment of Facility Terms by EIB
October 31, 2023
Via
Investor Brand Network
Exposures
COVID-19
European Investment Bank (EIB) considering extending maturity of its financial facility contract with Scinai Immunotherapeutics in light of Scinai’s recent strategic pivot
October 31, 2023
From
Scinai Immunotherapeutics Ltd.
Via
GlobeNewswire
Scinai Reports Third Quarter 2023 Financial Results and Provides Business Update
October 31, 2023
From
Scinai Immunotherapeutics Ltd.
Via
GlobeNewswire
Study Identifies Immune Cells Responsible for Severe Asthma
October 30, 2023
Via
Investor Brand Network
BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Announces Participation at BIO-Europe Munich 2023
October 30, 2023
Via
Investor Brand Network
Scinai Immunotherapeutics to Attend BIO-Europe Munich 2023
October 30, 2023
From
Scinai Immunotherapeutics Ltd.
Via
GlobeNewswire
Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) to Showcase Its Boutique End-to-End CDMO Services at the Premier CPHI Barcelona Event
October 27, 2023
Via
Investor Brand Network
Five Ways to Treat Infectious Diseases While Keeping Antimicrobial Resistance in Check
October 23, 2023
Via
Investor Brand Network
Exposures
COVID-19
Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Reports Promising Results in Its Pursuit of Safe, Effective Treatments for Large, Underserved Population of Plaque Psoriasis Patients
October 23, 2023
Via
Investor Brand Network
Researchers ID Biomarker That Could Improve Autoimmune Disease Treatment
October 17, 2023
Via
Investor Brand Network
12 Health Care Stocks Moving In Thursday's After-Market Session
October 12, 2023
Via
Benzinga
Syndromic Testing Could Transform Infectious Disease Diagnosis
October 11, 2023
Via
Investor Brand Network
Exposures
COVID-19
12 Health Care Stocks Moving In Tuesday's Intraday Session
October 10, 2023
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
